Reactive oxygen species and glucocorticoid-induced hypertension

Clinical and Experimental Pharmacology and Physiology

Volumn 35, Issue 4, 2008, Pages 477-482

  Ong, Sharon L H ^a   Zhang, Yi ^a   Whitworth, Judith A ^a  

^a Biology and Environment   (Australia)

Author keywords

Glucocorticoids; Hypertension; Nitric oxide; Oxidative stress; Reactive oxygen species

Indexed keywords

ACETYLCYSTEINE; ANTIOXIDANT; BIOLOGICAL MARKER; CORTICOTROPIN; DEXAMETHASONE; ENDOTHELIAL NITRIC OXIDE SYNTHASE; ENZYME INHIBITOR; GLUCOCORTICOID; NITRIC OXIDE; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; SUPEROXIDE; TEMPOL; VITAMIN; XANTHINE OXIDASE;

BLOOD PRESSURE; CONFERENCE PAPER; DISORDERS OF MITOCHONDRIAL FUNCTIONS; DRUG EFFECT; ENZYME ACTIVITY; ENZYME INHIBITION; GENE EXPRESSION; HYPERTENSION; MITOCHONDRION; NONHUMAN; OXIDATIVE STRESS; PATHOGENESIS; UPREGULATION; VASCULARIZATION;

ANIMALS; GLUCOCORTICOIDS; HUMANS; HYPERTENSION; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES;

EID: 40149096846     PISSN: 03051870     EISSN: 14401681     Source Type: Journal    
DOI: 10.1111/j.1440-1681.2008.04900.x     Document Type: Conference Paper

References (81)

1. Bayir H. Reactive oxygen species. Crit. Care Med. 2005 33 (Suppl S498 501.
2. Crawford DR, Davies KJ. Adaptive response and oxidative stress. Environ. Health Perspect 1994 102 (Suppl 25 8.
3. Dhalla NS, Temsah RM, Netticadan T. Role of oxidative stress in cardiovascular diseases. J. Hypertens. 2000 18 : 655 73.
4. Valko M, Leibfritz D, Moncol J, Cronin MTD, Mazur M, Telser J. Free radicals and antioxidants in normal physiological functions and human disease. Int. J. Biochem. Cell Biol. 2007 39 : 44 84.
5. Sayre LM, Smith MA, Perry G. Chemistry and biochemistry of oxidative stress in neurodegenerative disease. Curr. Med. Chem. 2001 8 : 721 38.
6. Kumar KV, Das UN. Are free radicals involved in the pathobiology of human essential hypertension? Free Radic. Res. Commun. 1993 19 : 59 66.
7. Armas-Padilla MC, Armas-Hernandez MJ, Sosa-Canache B et al. Nitric oxide and malondialdehyde in human hypertension. Am. J. Ther. 2007 14 : 172 6.
8. Lerman LO, Nath KA, Rodriguez-Porcel M et al. Increased oxidative stress in experimental renovascular hypertension. Hypertension 2001 37 : 541 6.
9. 2-isoprostanes in rats. Hypertension 2000 35 : 476 9.
10. Haas JA, Krier JD, Bolterman RJ, Juncos LA, Romero JC. Low-dose angiotensin II increases free isoprostane levels in plasma. Hypertension 1999 34 : 983 6.
11. Wu R, Millette E, Wu L, de Champlain J. Enhanced superoxide anion formation in vascular tissues from spontaneously hypertensive and desoxycorticosterone acetate-salt hypertensive rats. J. Hypertens. 2001 19 : 741 8.
12. Nabha L, Garbern JC, Buller CL, Charpie JR. Vascular oxidative stress precedes high blood pressure in spontaneously hypertensive rats. Clin. Exp. Hypertens. 2005 27 : 71 82.
13. Kushiro T, Fujita H, Hisaki R. et al. Oxidative stress in the Dahl salt-sensitive hypertensive rat. Clin. Exp. Hypertens. 2005 27 : 9 15.
14. Swei A, Lacy F, DeLano FA, Schmid-Schonbein GW. Oxidative stress in the Dahl hypertensive rat. Hypertension 1997 30 : 1628 33.
15. Vaziri ND, Wang XQ, Oveisi F, Rad B. Induction of oxidative stress by glutathione depletion causes severe hypertension in normal rats. Hypertension 2000 36 : 142 6.
16. Harrison DG, Gongora MC, Guzik TJ, Widder J. Oxidative stress and hypertension. J. Am. Soc. Hypertens. 2007 1 : 30 44.
17. Williamson PM, Kelly JJ, Whitworth JA. Dose-response relationships and mineralocorticoid activity in cortisol-induced hypertension in humans. J. Hypertens. 1996 14 (Suppl S37 41.
18. Whitworth JA, Williamson PM, Brown MA, Morris MJ. Neuropeptide Y in cortisol-induced hypertension in male volunteers. Clin. Exp. Pharmacol. Physiol. 1994 21 : 435 8.
19. Macefield VG, Williamson PM, Wilson LR, Kelly JJ, Gandevia SC, Whitworth JA. Muscle sympathetic vasoconstrictor activity in hydrocortisone-induced hypertension in humans. Blood Press. 1998 7 : 215 22.
20. Turner SW, Wen C, Li M, Whitworth JA. L-Arginine prevents corticotropin-induced increases in blood pressure in the rat. Hypertension 1996 27 : 184 9.
21. Wen C, Li M, Whitworth JA. Role of nitric oxide in adrenocorticotrophin- induced hypertension: l-ARGININE effects reversed by N-nitro-L-arginine. Clin. Exp. Pharmacol. Physiol. 2000 27 : 887 90.
22. Wen C, Li M, Fraser T, Wang J, Turner SW, Whitworth JA. l-arginine partially reverses established adrenocorticotrophin-induced hypertension and nitric oxide deficiency in the rat. Blood. Press. 2000 9 : 298 304.
23. Pirpiris M, Sudhir K, Yeung S, Jennings G, Whitworth JA. Pressor responsiveness in corticosteroid-induced hypertension in humans. Hypertension 1992 19 : 567 74.
24. Okuno T, Suzuki H, Saruta T. Dexamethasone hypertension in rats. Clin. Exp. Hypertens. 1981 3 : 1075 86.
25. Hu L, Zhang Y, Lim PS et al. Apocynin but not l-arginine prevents and reverses dexamethasone-induced hypertension in the rat. Am. J. Hypertens. 2006 19 : 413 18.
26. Tam SH, Kelly JJ, Williamson PM, Whitworth JA. Reflex sympathetic function in cortisol-induced hypertension in humans. Clin. Exp. Hypertens. 1997 19 : 479 93.
27. Kelly JJ, Tam SH, Williamson PM, Lawson J, Whitworth JA. The nitric oxide system and cortisol-induced hypertension in humans. Clin. Exp. Pharmacol. Physiol. 1998 25 : 945 6.
28. Wallerath T, Godecke A, Molojavyi A, Li H, Schrader J, Forstermann U. Dexamethasone lacks effect on blood pressure in mice with a disrupted endothelial NO synthase gene. Nitric Oxide 2004 10 : 36 41.
29. Whitworth JA, Schyvens CG, Zhang Y, Andrews MC, Mangos GJ, Kelly JJ. The nitric oxide system in glucocorticoid-induced hypertension. J. Hypertens. 2002 20 : 1035 43.
30. Mangos GJ, Turner SW, Fraser TB, Whitworth JA. The role of corticosterone in corticotrophin (ACTH)-induced hypertension in the rat. J. Hypertens. 2000 18 : 1849 55.
31. Simmons WW, Closs EI, Cunningham JM, Smith TW, Kelly RA. Cytokines and insulin induce cationic amino acid transporter (CAT) expression in cardiac myocytes. J. Biol. Chem. 1996 271 : 11 694 702.
32. Simmons WW, Ungureanu-Longrois D, Smith GK, Smith TW, Kelly RA. Glucocorticoids regulate inducible nitric oxide synthase by inhibiting tetrahydrobiopterin synthesis and l-arginine transport. J. Biol. Chem. 1996 271 : 23 928 37.
33. Chin-Dusting JPF, Ahlers BA, Kaye DM, Kelly JJ, Whitworth JA. L-Arginine transport in humans with cortisol-induced hypertension. Hypertension 2003 41 : 1336 40.
34. Li M, Fraser T, Wang J, Whitworth JA. Dexamethasone-induced hypertension in the rat: Effects of l-arginine. Clin. Exp. Pharmacol. Physiol. 1997 24 : 730 2.
35. Wallerath T, Witte K, Schafer SC et al. Down-regulation of the expression of endothelial NO synthase is likely to contribute to glucocorticoid-mediated hypertension. Proc. Natl Acad. Sci. USA 1999 96 : 13 357 62.
36. Lou Y-K, Wen C, Li M et al. Decreased renal expression of nitric oxide synthase isoforms in adrenocorticotropin-induced and corticosterone-induced hypertension. Hypertension 2001 37 : 1164 70.
37. Radi R, Cassina A, Hodara R, Quijano C, Castro L. Peroxynitrite reactions and formation in mitochondria. Free Radic. Biol. Med. 2002 33 : 1451 64.
38. Iuchi T, Akaike M, Mitsui T et al. Glucocorticoid excess induces superoxide production in vascular endothelial cells and elicits vascular endothelial dysfunction. Circ. Res. 2003 92 : 81 7.
39. Tan C, Schyvens CGPA, McKenzie KU, Zhang Y, Whitworth JA. The effect of adrenocorticotropic hormone treatment on nitrotyrosine levels in rat organs. Clin. Exp. Pharmacol. Physiol. 2005 32 : A26.
40. Suzuki H, Swei A, Zweifach BW, Schmid-Schonbein GW. In vivo evidence for microvascular oxidative stress in spontaneously hypertensive rats: Hydroethidine microfluorography. Hypertension 1995 25 : 1083 9.
41. Paravicini TM, Gulluyan LM, Dusting GJ, Drummond GR. Increased NADPH oxidase activity, gp91phox expression, and endothelium-dependent vasorelaxation during neointima formation in rabbits. Circ. Res. 2002 91 : 54 61.
42. Rajagopalan S, Kurz S, Munzel T et al. Angiotensin II-mediated hypertension in the rat increases vascular superoxide production via membrane NADH/NADPH oxidase activation. Contribution to alterations of vasomotor tone. J. Clin. Invest. 1996 97 : 1916 23.
43. Dobrian AD, Schriver SD, Prewitt RL. Role of angiotensin II and free radicals in blood pressure regulation in a rat model of renal hypertension. Hypertension 2001 38 : 361 6.
44. Mondo CK, Zhang Y, Possamai VDM et al. N-Acetylcysteine antagonizes the development but does not reverse ACTH-induced hypertension in the rat. Clin. Exp. Hypertens. 2006 28 : 73 84.
45. Zhang Y, Jang R, Mori TA et al. The anti-oxidant Tempol reverses and partially prevents adrenocorticotrophic hormone-induced hypertension in the rat. J. Hypertens. 2003 21 : 1513 18.
46. Dalle-Donne I, Rossi R, Colombo R, Giustarini D, Milzani A. Biomarkers of oxidative damage in human disease. Clin. Chem. 2006 52 : 601 23.
47. Zhang Y, Chan MMK, Andrews MC et al. Apocynin but not allopurinol prevents and reverses adrenocorticotropic hormone-induced hypertension in the rat. Am. J. Hypertens. 2005 18 : 910 16.
48. Zhang Y, Croft KD, Mori TA, Schyvens CG, McKenzie KUS, Whitworth JA. The antioxidant tempol prevents and partially reverses dexamethasone-induced hypertension in the rat. Am. J. Hypertens. 2004 17 : 260 5.
49. Miao Y, Zhang Y, Lim PS et al. Folic Acid prevents and partially reverses glucocorticoid-induced hypertension in the rat. Am. J. Hypertens. 2007 20 : 304 10.
50. Zhang Y, Miao Y, Whitworth JA. Aspirin prevents and partially reverses adrenocorticotrophic hormone-induced hypertension. Am. J. Hypertens. 2007 (in press).
51. Schyvens CG, Andrews MC, Tam R et al. Antioxidant vitamins and adrenocorticotrophic hormone-induced hypertension in rats. Clin. Exp. Hypertens. 2007 29 : 465 78
52. Girouard H, Chulak C, Wu L, Lejossec M, de Champlain J. N-acetylcysteine improves nitric oxide and α-adrenergic pathways in mesenteric beds of spontaneously hypertensive rats. Am. J. Hypertens. 2003 16 : 577 84.
53. Ruffmann R, Wendel A. GSH rescue by N-acetylcysteine. Klin. Wochenschr. 1991 69 : 857 62.
54. Zhang L, Fujii S, Igarashi J, Kosaka H. Effects of thiol antioxidant on reduced nicotinamide adenine dinucleotide phosphate oxidase in hypertensive Dahl salt-sensitive rats. Free Radic. Biol. Med. 2004 37 : 1813 20.
55. Seo M-Y, Lee S-M. Protective effect of low dose of ascorbic acid on hepatobiliary function in hepatic ischemia/reperfusion in rats. J. Hepatol. 2002 36 : 72 7.
56. Wassmann S, Wassmann K, Nickenig G. Modulation of oxidant and antioxidant enzyme expression and function in vascular cells. Hypertension 2004 44 : 381 6.
57. Rajashree S, Puvanakrishnan R. Dexamethasone induced alterations in the levels of proteases involved in blood pressure homeostasis and blood coagulation in rats. Mol. Cell. Biochem. 1999 197 : 203 8.
58. Carletti M, Cantiello M, Giantin M et al. Serum antioxidant enzyme activities and oxidative stress parameters as possible biomarkers of exposure in veal calves illegally treated with dexamethasone. Toxicol. In Vitro 2007 21 : 277 83.
59. Touyz RM, Schiffrin EL. Reactive oxygen species in vascular biology: Implications in hypertension. Histochem. Cell Biol. 2004 122 : 339 52.
60. Cai H, Harrison DG. Endothelial dysfunction in cardiovascular diseases: The role of oxidant stress. Circ. Res. 2000 87 : 840 4.
61. Mohazzab KM, Kaminski PM, Wolin MS. NADH oxidoreductase is a major source of superoxide anion in bovine coronary artery endothelium. Am. J. Physiol. 1994 266 : H2568 72.
62. Pagano PJ, Tornheim K, Cohen RA. Superoxide anion production by rabbit thoracic aorta: Effect of endothelium-derived nitric oxide. Am. J. Physiol. 1993 265 : H707 12.
63. Mohazzab KM, Wolin MS. Sites of superoxide anion production detected by lucigenin in calf pulmonary artery smooth muscle. Am. J. Physiol. 1994 267 : L815 22.
64. Pagano PJ, Clark JK, Cifuentes-Pagano ME, Clark SM, Callis GM, Quinn MT. Localization of a constitutively active, phagocyte-like NADPH oxidase in rabbit aortic adventitia: Enhancement by angiotensin II. Proc. Natl Acad. Sci. USA 1997 94 : 14 483 8.
65. Pagano PJ, Ito Y, Tornheim K, Gallop PM, Tauber AI, Cohen RA. An NADPH oxidase superoxide-generating system in the rabbit aorta. Am. J. Physiol. 1995 268 : H2274 80.
66. Bengtsson SHM, Gulluyan LM, Dusting GJ, Drummond GR. Novel isoforms of NADPH oxidase in vascular physiology and pathophysiology. Clin. Exp. Pharmacol. Physiol. 2003 30 : 849 54.
67. Lassegue B, Clempus RE. Vascular NAD(P)H oxidases: Specific features, expression, and regulation. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2003 285 : R277 97.
68. Groemping Y, Rittinger K. Activation and assembly of the NADPH oxidase: A structural perspective. Biochem. J. 2005 386 : 401 16.
69. Wen C, Fraser T, Li M, Turner SW, Whitworth JA. Haemodynamic mechanisms of corticotropin (ACTH)-induced hypertension in the rat. J. Hypertens. 1999 17 : 1715 23.
70. Berry CE, Hare JM. Xanthine oxidoreductase and cardiovascular disease. Molecular mechanisms and pathophysiological implications. J. Physiol. 2004 555 : 589 606.
71. Suzuki H, DeLano FA, Parks DA et al. Xanthine oxidase activity associated with arterial blood pressure in spontaneously hypertensive rats. Proc. Natl Acad. Sci. USA 1998 95 : 4754 9.
72. Ong SLH, Vickers JJ, Zhang Y, McKenzie KUS, Walsh CE, Whitworth JA. Role of xanthine oxidase in dexamethasone-induced hypertension in rats. Clin. Exp. Pharmacol. Physiol. 2007 34 : 517 19.
73. Kuzkaya N, Weissmann N, Harrison DG, Dikalov S. Interactions of peroxynitrite, tetrahydrobiopterin, ascorbic acid, and thiols: Implications for uncoupling endothelial nitric-oxide synthase. J. Biol. Chem. 2003 278 : 22 546 54.
74. Schafer SC, Wallerath T, Closs EI et al. Dexamethasone suppresses eNOS and CAT-1 and induces oxidative stress in mouse resistance arterioles. Am. J. Physiol. Heart Circ. Physiol. 2005 288 : H436 44.
75. Vasquez-Vivar J, Martasek P, Whitsett J, Joseph J, Kalyanaraman B. The ratio between tetrahydrobiopterin and oxidized tetrahydrobiopterin analogues controls superoxide release from endothelial nitric oxide synthase: An EPR spin trapping study. Biochem. J. 2002 362 : 733 9.
76. Zhang Y, Pang T, Earl J, Schyvens CG, McKenzie KU, Whitworth JA. Role of tetrahydrobiopterin in adrenocorticotropic hormone-induced hypertension in the rat. Clin. Exp. Hypertens. 2004 26 : 231 41.
77. Madamanchi NR, Runge MS. Mitochondrial dysfunction in atherosclerosis. Circ. Res. 2007 100 : 460 73.
78. Han D, Antunes F, Canali R, Rettori D, Cadenas E. Voltage-dependent anion channels control the release of the superoxide anion from mitochondria to cytosol. J. Biol. Chem. 2003 278 : 5557 63.
79. Ballinger SW, Patterson C, Knight-Lozano CA et al. Mitochondrial integrity and function in atherogenesis. Circulation 2002 106 : 544 9.
80. Ballinger SW. Mitochondrial dysfunction in cardiovascular disease. Free Radic. Biol. Med. 2005 38 : 1278 95.
81. Midaoui AEL, Elimadi A, Wu L, Haddad PS, de Champlain J. Lipoic acid prevents hypertension, hyperglycemia, and the increase in heart mitochondrial superoxide production. Am. J. Hypertens. 2003 16 : 173 9.